Shoshana Morecki
Department of Bone Marrow Transplantation & Cancer Immunotherapy
Cell Therapy & Transplantation Research Laboratory
Hadassah University Hospital
Jerusalem
Israel
Name/email consistency: high
- Induction of graft-versus-leukemia (GVL) effect without graft-versus-host disease (GVHD) by pretransplant donor treatment with immunomodulators. Morecki, S., Yacovlev, E., Gelfand, Y., Shabat, Y., Slavin, S. Biol. Blood Marrow Transplant. (2009)
- Induction of long-lasting antitumor immunity by concomitant cell therapy with allogeneic lymphocytes and trifunctional bispecific antibody. Morecki, S., Lindhofer, H., Yacovlev, E., Gelfand, Y., Ruf, P., Slavin, S. Exp. Hematol. (2008)
- CpG-induced myeloid CD11b+Gr-1+ cells efficiently suppress T cell-mediated immunoreactivity and graft-versus-host disease in a murine model of allogeneic cell therapy. Morecki, S., Gelfand, Y., Yacovlev, E., Eizik, O., Shabat, Y., Slavin, S. Biol. Blood Marrow Transplant. (2008)
- Pretransplant treatment of donors with immunomodulators to control graft-versus-host disease (GVHD) in transplant recipients. Morecki, S., Yacovlev, E., Gelfand, Y., Eizik, O., Slavin, S. Exp. Hematol. (2007)
- Use of trifunctional bispecific antibodies to prevent graft versus host disease induced by allogeneic lymphocytes. Morecki, S., Lindhofer, H., Yacovlev, E., Gelfand, Y., Slavin, S. Blood (2006)
- Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect. Morecki, S., Yacovlev, E., Gelfand, Y., Vilensky, A., Slavin, S. Biol. Blood Marrow Transplant. (2004)
- Effect of KRN7000 on induced graft-vs-host disease. Morecki, S., Panigrahi, S., Pizov, G., Yacovlev, E., Gelfand, Y., Eizik, O., Slavin, S. Exp. Hematol. (2004)
